1. Home
  2. BELFB vs ABUS Comparison

BELFB vs ABUS Comparison

Compare BELFB & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BELFB
  • ABUS
  • Stock Information
  • Founded
  • BELFB 1949
  • ABUS 2005
  • Country
  • BELFB United States
  • ABUS United States
  • Employees
  • BELFB N/A
  • ABUS N/A
  • Industry
  • BELFB
  • ABUS Biotechnology: Pharmaceutical Preparations
  • Sector
  • BELFB
  • ABUS Health Care
  • Exchange
  • BELFB Nasdaq
  • ABUS Nasdaq
  • Market Cap
  • BELFB 865.9M
  • ABUS 711.2M
  • IPO Year
  • BELFB N/A
  • ABUS N/A
  • Fundamental
  • Price
  • BELFB $143.88
  • ABUS $4.20
  • Analyst Decision
  • BELFB Strong Buy
  • ABUS Strong Buy
  • Analyst Count
  • BELFB 4
  • ABUS 3
  • Target Price
  • BELFB $129.75
  • ABUS $5.67
  • AVG Volume (30 Days)
  • BELFB 137.8K
  • ABUS 1.0M
  • Earning Date
  • BELFB 10-22-2025
  • ABUS 11-05-2025
  • Dividend Yield
  • BELFB 0.19%
  • ABUS N/A
  • EPS Growth
  • BELFB N/A
  • ABUS N/A
  • EPS
  • BELFB 4.05
  • ABUS N/A
  • Revenue
  • BELFB $594,034,000.00
  • ABUS $15,416,000.00
  • Revenue This Year
  • BELFB $25.48
  • ABUS $138.02
  • Revenue Next Year
  • BELFB $5.57
  • ABUS N/A
  • P/E Ratio
  • BELFB $34.62
  • ABUS N/A
  • Revenue Growth
  • BELFB 6.08
  • ABUS 53.23
  • 52 Week Low
  • BELFB $58.00
  • ABUS $2.71
  • 52 Week High
  • BELFB $145.79
  • ABUS $4.73
  • Technical
  • Relative Strength Index (RSI)
  • BELFB 70.12
  • ABUS 84.85
  • Support Level
  • BELFB $130.13
  • ABUS $3.60
  • Resistance Level
  • BELFB $141.80
  • ABUS $4.10
  • Average True Range (ATR)
  • BELFB 4.33
  • ABUS 0.17
  • MACD
  • BELFB -0.14
  • ABUS 0.06
  • Stochastic Oscillator
  • BELFB 91.06
  • ABUS 83.33

About BELFB Bel Fuse Inc. Class B

Bel Fuse Inc designs and manufactures electronic components that protect and connect electronic circuits. Its product portfolio is divided into three categories: magnetic solutions, power solutions & protection, and connectivity solutions. These products are used for the computer, networking, telecommunications, transportation and defense/aerospace, automotive, medical, and consumer electronics industries. Its geographical segments are the United States, Macao, United Kingdom, Slovakia, Germany, Switzerland, and All other foreign countries. Majority of the revenue is derived from United States.

About ABUS Arbutus Biopharma Corporation

Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.

Share on Social Networks: